AXIM (AXIM Biotechnologies) EPS without NRI: $-0.00 (TTM As of Jun. 2025)


What is AXIM Biotechnologies EPS without NRI?

AXIM Biotechnologies AXIM EPS without NRI is $-0.00 as of Jun. 2025. The stock has 7 warning signs investors should review. Among 1,176 Biotechnology companies, AXIM Biotechnologies ranks better than 84.44% on this metric.

AXIM Biotechnologies's earnings per share without non-recurring items for the three months ended in Jun. 2025 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2025 was $-0.00.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 49.70% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 32.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for AXIM Biotechnologies's EPS without NRI or its related term are showing as below:

AXIM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -300   Med: 18.9   Max: 49.7
Current: 49.7

During the past 13 years, AXIM Biotechnologies's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 49.70% per year. The lowest was -300.00% per year. And the median was 18.90% per year.

AXIM's 3-Year EPS without NRI Growth Rate is ranked better than
84.44% of 1176 companies
in the Biotechnology industry
Industry Median: 16.8 vs AXIM: 49.70

AXIM Biotechnologies's EPS (Diluted) for the three months ended in Jun. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00.

AXIM Biotechnologies's EPS (Basic) for the three months ended in Jun. 2025 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00.


AXIM Biotechnologies  (OTCPK:AXIM) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


AXIM Biotechnologies EPS without NRI Related Terms


AXIM Biotechnologies EPS without NRI Historical Data

* Premium members only.

The historical data trend for AXIM Biotechnologies's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AXIM Biotechnologies EPS without NRI Chart

AXIM Biotechnologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.06 -0.04 -0.02 -0.01

AXIM Biotechnologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.01 0.00 -0.00 0.00

AXIM vs HEPA, SCNI, BZYR: EPS without NRI Comparison

For the Biotechnology subindustry, AXIM Biotechnologies's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AXIM Biotechnologies PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's PE Ratio without NRI falls into.



AXIM Biotechnologies EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-0.00 mean?
AXIM Biotechnologies (AXIM) has a EPS without NRI of $-0.00 as of Jun. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on AXIM Biotechnologies and its competitors. According to the industry distribution chart, AXIM Biotechnologies ranks #183 out of 1176 companies in the Biotechnology industry, placing it in the top 15.6%.
Is AXIM Biotechnologies' EPS without NRI too high?
AXIM Biotechnologies' current EPS without NRI is $-0.00. Based on the distribution chart, AXIM Biotechnologies ranks #183 out of 1176 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does AXIM Biotechnologies' EPS without NRI compare to HEPA and SCNI?
According to the Biotechnology industry distribution chart, AXIM Biotechnologies ranks #183 out of 1176 companies for EPS without NRI. This places AXIM Biotechnologies in the top 16% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 16.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.80, based on 1,176 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on AXIM Biotechnologies and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AXIM Biotechnologies's current EPS without NRI is $-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current EPS without NRI of $-0.00. The current EPS without NRI is $-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current EPS without NRI is $-0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.